Advertisement
Advertisement
PBYI
PUMA BIOTECHNOLOGY INC
6.70
USDSponsored
+0.21
+3.32%
Feb 02, 11:10 UTC -5
Open
PBYI Earnings Reports
Positive Surprise Ratio
PBYI beat 29 of 40 last estimates.
73%
Next Report
Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$69.97M
/$0.19
Implied change from Q3 25 (Revenue/ EPS)
+28.39%
/+11.76%
Implied change from Q4 24 (Revenue/ EPS)
+18.40%
/-51.28%
PUMA BIOTECHNOLOGY INC earnings per share and revenue
On Nov 06, 2025, PBYI reported earnings of 0.17 USD per share (EPS) for Q3 25, beating the estimate of 0.04 USD, resulting in a 270.37% surprise. Revenue reached 54.50 million, compared to an expected 52.02 million, with a 4.77% difference. The market reacted with a +22.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.19 USD, with revenue projected to reach 69.97 million USD, implying an increase of 11.76% EPS, and increase of 28.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
What were PUMA BIOTECHNOLOGY INC's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PUMA BIOTECHNOLOGY INC reported EPS of $0.17, beating estimates by 270.37%, and revenue of $54.50M, 4.77% above expectations.
How did the market react to PUMA BIOTECHNOLOGY INC's Q3 2025 earnings?
The stock price moved up 22.24%, changed from $4.90 before the earnings release to $5.99 the day after.
When is PUMA BIOTECHNOLOGY INC expected to report next?
The next earning report is scheduled for Feb 26, 2026.
What are the forecasts for PUMA BIOTECHNOLOGY INC's next earnings report?
Based on 4
analysts, PUMA BIOTECHNOLOGY INC is expected to report EPS of $0.19 and revenue of $69.97M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement